Locations:
Search IconSearch
February 27, 2023/Lerner College of Medicine

8 CCLCM Faculty Members Promoted

hands clapping

Congratulations to the following faculty members who were recently promoted from either assistant or associate professor, effective Jan. 1, 2023:

Jalal M. Abu-Shaweesh, MD
Professor, Pediatrics

Andrej Alfirevic, MD
Professor, Anesthesiology

Samantha Anne, MD
Professor, Otolaryngology

Christine M. O’Connor, PhD
Associate Professor, Molecular Medicine

Sujata Rao, PhD
Associate Professor, Ophthalmology

Amy Mikilene Burleson Sullivan, PsyD
Associate Professor Medicine

Jonathan J. Taliercio, DO
Associate Professor, Medicine

Jijun Xu, MD, PhD
Associate Professor, Anesthesiology

Seeking a promotion represents an important step in a faculty member’s career. A promotion demonstrates not only a faculty member’s dedication to teaching, research and professional service, but also a commitment to their career and engagement in the profession.

Faculty who are either assistant or associate professors and want to advance must go through a 9-18 month+ promotion cycle. Promotions are approved twice per year; there are no deadlines to apply.

We applaud these eight faculty members who took the time to attain their promotion, and we thank them for the service they provide in developing future physician investigators at CCLCM.

FACULTY: If you wish to be promoted, visit CCLCM Faculty Affairs Promotions to learn more. All applications are submitted online via our portal. There is no deadline for submitting a promotion application.

Latest from the Newsroom

Beri Ridgeway, M.D.

Cleveland Clinic Appoints Beri Ridgeway, M.D., as President of Cleveland Clinic London

Genediting Therapy Shows Success Against Severe Sickle Cell Disease

Gene Editing Therapy Shows Success Against Severe Sickle Cell Disease

Cleveland Clinic's Main Campus lobby

Mandel Foundation Donates $50 Million to Improve Access to Care at Cleveland Clinic

Blood pressure cuff

Experimental Monthly Injectable Reduces a Key Regulator of Blood Pressure

GLP-1 injection pen with a stethoscope

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease

Hospital Care At Home

Cleveland Clinic Introduces Hospital Care At Home in Ohio

Image of a scaled and tape measure

What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights

Illustration of digital medical records

AI-Driven Chart Review Accurately Identifies Potential Rare Disease Trial Participants in New Study